Učitavanje...

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy

RATIONALE: Regorafenib represents a treatment option in heavily pretreated patients affected by metastatic colorectal cancer (mCRC). Its safety profile is typical of small-molecule tyrosine-kinase inhibitors (TKIs) and most adverse events are manageable. PATIENT CONCERNS: A 56 years-old Caucasian ma...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Medicine (Baltimore)
Glavni autori: Quirino, Michela, Rossi, Sabrina, Schinzari, Giovanni, Basso, Michele, Strippoli, Antonia, Cassano, Alessandra, Barone, Carlo
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406055/
https://ncbi.nlm.nih.gov/pubmed/28422839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006522
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!